Biotech in 2024 saw a year of progress, challenges, and new opportunities. In his recent article for Labiotech, Jules Adam captured the key moments that shaped the industry.
LongeVC Operating Partner Artem Trotsyuk contributed to the conversation, offering his perspective on the trends driving innovation and investment in biotech.